2017 to 2022 Saw Rise in ED Orders for Buprenorphine for Opioid Use Disorder
By Lori Solomon HealthDay Reporter
.jpg?width=1200)
THURSDAY, Feb. 27, 2025 -- Emergency clinicians in California increased prescription of buprenorphine for opioid use disorder (OUD) from 2017 to 2022, according to a study published online Feb. 19 in the Journal of the American Medical Association.
Annette M. Dekker, M.D., from the University of California, Los Angeles, and colleagues examined emergency clinician buprenorphine initiation for OUD, subsequent prescriptions, and changes over time in California in an observational retrospective study. The analysis included data from the California Controlled Substance Utilization Review and Evaluation System (2017 through 2022).
The researchers identified 345,024 patients receiving 3.8 million buprenorphine prescriptions from 21,099 clinicians in California during the study period. At the time of first buprenorphine prescription, patients' mean age was 37 years and 67 percent were male. Over time, emergency clinicians increased from 2 percent (78 clinicians) to 16 percent (1,789 clinicians) of buprenorphine prescribers. Similarly, there was an increase in the proportion of buprenorphine initiation prescriptions by emergency clinicians (0.1 percent [53 clinicians] to 5 percent [4,493 clinicians]). For patients receiving an emergency department initiation, the continuation ratio to receive a second prescription within 40 days was 2.8. Within 40 days of emergency department buprenorphine initiation, the continuation ratio for patients to start 180 days or more of continuous prescriptions was 18.3. The continuation ratio was 9.1 within one year.
"For a lot of people who use opioids, the emergency department might be the only touch point they have with the health care system, so it’s a huge window of opportunity to make a difference," Dekker said in a statement.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
AAP Offers Guidance for Tapering of Opioids to Prevent Withdrawal in Children
TUESDAY, Aug. 19, 2025 -- A plan for tapering opioids should be developed to minimize withdrawal symptoms in children receiving opioids for five or more days, according to a...
Stigma of Substance Use Disorder Varies by Condition, Provider
WEDNESDAY, July 30, 2025 -- Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in...
Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery
TUESDAY, July 29, 2025 -- Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain among patients undergoing...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.